| dbo:abstract
|
- Rockwell Medical Inc., based in Wixom, Michigan, focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD). The company's primary customers are dialysis providers such as DaVita Inc. (46% of 2018 revenues). The company was founded in 1996. (en)
|
| dbo:assets
| |
| dbo:equity
| |
| dbo:foundingYear
| |
| dbo:industry
| |
| dbo:location
| |
| dbo:netIncome
| |
| dbo:numberOfEmployees
|
- 269 (xsd:nonNegativeInteger)
|
| dbo:revenue
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 4313 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:assets
| |
| dbp:equity
| |
| dbp:homepage
| |
| dbp:industry
| |
| dbp:keyPeople
|
- Stuart Paul, President and CEOAjay Gupta, Chief Scientific OfficerRaymond D. Pratt, Chief Medical Officer (en)
|
| dbp:location
| |
| dbp:logo
| |
| dbp:name
|
- Rockwell Medical Inc. (en)
|
| dbp:netIncome
| |
| dbp:numEmployees
| |
| dbp:revenue
| |
| dbp:tradedAs
|
- Russell 2000 Index component (en)
- NASDAQ:RMTI (en)
|
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Rockwell Medical Inc., based in Wixom, Michigan, focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD). The company's primary customers are dialysis providers such as DaVita Inc. (46% of 2018 revenues). The company was founded in 1996. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Rockwell Medical Inc. (en)
|
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
